Treatment of type 1 diabetes with anti-CD3 monoclonal antibody.
Glandt
Mariela
M
Division of Endocrinology and the Naomi Berrie Diabetes Center, College of Physicians and Surgeons, Columbia University, New York, NY and the Pacific Northwest Research Institute, Seattle, WA.
Hagopian
William
W
Herold
Kevan C
KC
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D015551:Autoimmunity; D017252:CD3 Complex / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D007515:Islets of Langerhans / Q000276:immunology / Q000503:physiopathology; D051379:Mice
D000911:Antibodies, Monoclonal; D017252:CD3 Complex